The inhibitory activities of the herbal extracts were assessed on the key enzymes that control the occurrence of some NCDs including type II diabetes (T2DM) (α-amylase and α-glucosidase), Alzheimer’s disease (AChE, BChE, and BACE-1) and hypertension (ACE). This evidence concerns the gene ACE and early-onset autosomal dominant Alzheimer disease.